Using tablet PCs in your practice

Article

John Warren, OD, discusses using tablets throughout a practice-for data and image review, patient education, and in the optical shop.

John Warren, OD, discussed using tablets during a special session, “Celebrating Technology,” at the 90th annual SECO International meeting in Atlanta.

Although tablet-like devices have been available for some time, Apple’s iPad revolutionized the concept by putting $499 devices in people’s hands, said the Racine, WI, optometrist, who founded RevolutionEHR, a Web-based electronic health records system for optometrists.

Tablets and EHR don’t necessarily go together, Dr. Warren said. Tablets work poorly for data entry due to the small screen size, which limits the amount of data that can be seen and entered. “None of the major systems in eyecare have released a tablet-enhanced version of their program yet,” he said.

Tablets are very useful for data and image review, however. Reviewing history with patients and showing images for patient education are ideal tasks for tablets.

Another good place for tablets is the optical. “The point-and-click or check boxes for entering optical jobs is great for tablets,” said Dr. Warren.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.